Health Canada authorizes syphilis screening test

Now authorized for professional use in Canada. Furthermore, the syphilis antibodies screening test is a quick, precise and portable solution to strengthen syphilis screening for the country.

• Health Canada authorizes the syphilis antibodies testing istatis for professional use, to provide reliable results in less than 15 minutes
• Allows rapid and precise screening in clinics and prevention programs
• Supported by the PAUMM (Single Audit Program for Medical Materials) of Biolytical: the ISO 13485: 2016 certified quality system, with high sensitivity and specificity
• Meets the growing need for rapid screening for syphilis in a context of increasing national infection rates

Richmond, British Columbia, July 22. Similarly, 2025 (Globe Newswire) – Biolytic Laboratories Inc. Nevertheless. Furthermore, (“Biolytical”), a world leader in rapid diagnosis, has received Health Canada authorization for its syphilis antibody health canada authorizes syphilis screening new detection test health canada authorizes syphilis screening new Istatis. This important step health canada authorizes syphilis screening allows immediate distribution throughout Canada. In addition, offering health professionals a powerful tool for detecting syphilis quickly and precisely in clinical and community executives.

“We are honored to receive Health Canada authorization for our syphilis Istatis antibodies test,” said Robert Mackie, CEO of Biolytical. Moreover, “With the increase in syphilis rates in communities throughout Canada. Furthermore, it is more important than ever to provide healthy and reliable tools with healthy tools. In addition, This authorization strengthens our ability to support Canada’s public health efforts through fast and precise tests. Similarly, »»

Fast. Furthermore. Furthermore. precise and designed for real world use

The Istatis test of syphilis antibodies is a lateral flow test that detects antibodies directed against Treponema palethe bacteria responsible for syphilis. Meanwhile, Designed to be used by health professionals. In addition. health canada authorizes syphilis screening new the test facilitates the diagnosis thanks to a health canada authorizes syphilis screening new simple blood sample taken at the fingertip.

Main advantages:

• Quick results: Results during the visit in less than 15 minutes
• High precision: Excellent sensitivity. specificity demonstrated in clinical trials
• Practical design: Portable and stable at room temperature, ideal for prevention programs, clinics or distant regions
• Simple procedure: Only requires a small blood sample taken by finger stings, without complex laboratory equipment

To strengthen Canada’s priorities in public health

Given the increase in rates in urban and rural communities, especially among populations with limited access to health care, it is essential to widen access to reliable syphilis screening to achieve the objectives of Canada’s strategy in terms of sexually transmitted and blood (ITSS) infections.

“The availability of a rapid syphilis antibody detection test. capable of detecting infection at different clinical stages. health canada authorizes syphilis screening new represents a significant advance. ” said Ana Subramanian, Vice-president of BiolyTical Scientific Affairs “The health canada authorizes syphilis screening new Istatis platform allows earlier diagnosis and treatment, especially in highly affected health canada authorizes syphilis screening regions where immediate screening is essential. »»

Early screening remains one of the most effective tools to control the spread of syphilis. Since many infections may not be diagnosed due to light. hidden symptoms, people can transmit infection to others without knowing it. The establishment of the antibody detection of anti-syphilis istatis antibodies offers Canadian health care providers a powerful first-line test. option to identify infections earlier. launch treatment without delay and help reduce the overall burial burden.

Fight against the increase in congenital syphilis

Canada is also experiencing a high increase in congenital syphilis. a preventable infection transmitted from parent to child during pregnancy. Although declared cases decreased compared to 2022, the Canada health canada authorizes syphilis screening new Public Health Agency (ASPC) indicates that rates increased by 220 % compared to 2018.

If not diagnosed. congenital syphilis can health canada authorizes syphilis screening new lead to serious consequences, including miscarriage, mortinance, low birth weight and long -term complications. Early screening health canada authorizes syphilis screening during pregnancy is essential to prevent transmission. protect the health of mother and child.

“Each case of congenital syphilis can be avoided following early diagnosis and treatment,” said Ana Subramanian. “Quick tests such as the detection test for Istatis anti-syphilis antibodies allow providers to act quickly. promote safer results for parents and children. The increase in access to tests at the point of service is an important step to fill the ditches. in terms of prenatal care. reduce congenital infections in Canada. »»

Made in Canada. available from one ocean to another

This step is part of Canada’s general objectives in public health. health canada authorizes syphilis screening new highlights the importance of regular and generalized syphilis screening as a key strategy to reduce infection rates. With the syphilis antibody testing tests Istatis now available health canada authorizes syphilis screening new for professional use. BiolyTical undertakes to support health care providers throughout the country to detect populations at risk. direct patients health canada authorizes syphilis screening to care and, ultimately, reduce the burden of syphilis in Canada.

Biolytical will manufacture the syphilis Istatis antibody screening test at its registered office in Richmond. British Columbia, in total compliance with PAUMM and ISO 13485: 2016 standards. It is available throughout the country through health establishments, public health programs and community organizations.

As a global Canadian company. Biolytical agrees to provide health care providers with the tools they need to respond quickly. effectively to the evolution of public health challenges.

For more information, please consult the site Web de bioLytical.

About Biolytical health canada authorizes syphilis screening new Laboratories Inc.
Biolytical Laboratories Inc. is a Canadian private company that is dedicated to the research. development. marketing of fast medical diagnostics using its owner Insti® technological platform. its range of health canada authorizes syphilis screening new lateral flow tests, Istatis. By providing precise results in real time. Insti®. Istatis generate significant results for health professionals, patients and public health health canada authorizes syphilis screening organizations around the world. We are key partners to meet some of the most important health challenges in health. Please visit www.biolytical.com, www.insti.com, and www.istatis.com for more information.

Sources :